25 year old labourer 3 years back presented with penile ulcer not treated. Later he presented with neurological symptoms for which he got treated. Test to monitor response to treatment is –
**Core Concept**
The underlying concept here is the diagnosis and treatment of syphilis, a sexually transmitted infection caused by the bacterium *Treponema pallidum*. The patient's presentation with a penile ulcer followed by neurological symptoms is consistent with secondary syphilis, which can involve the central nervous system.
**Why the Correct Answer is Right**
The correct answer is based on the fact that syphilis is a treatable infection, and monitoring the response to treatment is crucial to prevent complications. The standard treatment for syphilis is penicillin, and the response to treatment is typically monitored using a non-treponemal test, such as the Venereal Disease Research Laboratory (VDRL) test or the Rapid Plasma Reagin (RPR) test. These tests measure the levels of antibodies against the lipoidal material released from damaged host cells and treponemal antigens. A four-fold decrease in the VDRL or RPR titer within 6-8 weeks of treatment is considered a good response to therapy.
**Why Each Wrong Option is Incorrect**
* **Option A:** This option is incorrect because the VDRL or RPR test is not used as a confirmatory test for syphilis. While it can detect the presence of antibodies, it is not specific and can give false-positive results.
* **Option B:** This option is incorrect because the fluorescent treponemal antibody absorption (FTA-ABS) test is a treponemal test that detects antibodies against *Treponema pallidum*. While it is specific for syphilis, it does not measure the response to treatment.
* **Option C:** This option is incorrect because the TPHA (Treponema pallidum hemagglutination assay) test is another treponemal test that detects antibodies against *Treponema pallidum*. Like the FTA-ABS test, it is specific but does not measure the response to treatment.
**Clinical Pearl / High-Yield Fact**
It is essential to note that a four-fold decrease in the VDRL or RPR titer within 6-8 weeks of treatment is considered a good response to therapy. Failure to achieve this decrease in titer may indicate treatment failure or reinfection.
**Correct Answer:** C.